Steve Mott joins DrugLogic
pharmafile | October 5, 2011 | Appointment | Research and Development |Â Â appointment, outcomes research, personalised medicine, pharmacovigilance, research and developmentÂ
Former Datapharm Communications chief executive Steve Mott has been apppointed UK managing director by DrugLogic.
The US firm develops analytical tools that help companies manage real world clinical data and Steve will oversee its expansion into Europe.
Related Content
Charity commits £800,000 to AI research into late breast cancer recurrence
Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate …
AI in pharma: From lab development to patient impact
In the decade to 2025, AI use in vaccine development has increased markedly but is …
PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …
